Assay of serotonin and related metabolites, enzymes, and drugs.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 13577424)

Published in Methods Biochem Anal on January 01, 1958

Authors

S UDENFRIEND, H WEISSBACH, B B BRODIE

Articles citing this

Radioisotopic studies of the binding, exchange, and distribution of 5-hydroxytryptamine synthesized from its radioactive precursor. J Physiol (1966) 1.27

Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol (1980) 1.11

Metabolism of an oral tryptophan load by women and evidence against the induction of tryptophan pyrrolase by oral contraceptives. Br J Clin Pharmacol (1978) 0.90

Abnormal forearm vascular responses in the carcinoid syndrome: the role of kinisns and kinin-generating system. J Clin Invest (1966) 0.86

Release of immunoreactive serotonin following acid perfusion of the duodenum. Ann Surg (1976) 0.86

CARCINOID SYNDROME DUE TO CARCINOID TUMOUR OF THE OVARY. Br Med J (1964) 0.85

Cushing's syndrome in association with carcinoid tumor. Ann Surg (1969) 0.82

Evidence for inhibition of the reuptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine in rat brain. Br J Pharmacol (1971) 0.79

THE INITIAL INACTIVATION OF PHENELZINE BY A MONOAMINE OXIDASE-LIKE SYSTEM IN VITRO AND IN VIVO. Br J Pharmacol Chemother (1965) 0.79

Impairment of pyridoxal phosphate dependent metabolic reactions in a child with subacute necrotizing encephalopathy. J Neurol Neurosurg Psychiatry (1969) 0.77

Auto-potentiation and potentiation by inhibition of monoamine oxidase of the sympathomimetic action of phenelzine and pheniprazine. Br J Pharmacol Chemother (1967) 0.77

On the question of the occurrence and metabolism of 5-hydroxytryptamine and related indole compounds in mammalian semen. Br J Pharmacol Chemother (1961) 0.76

Prostaglandin E1 causes sedation and increases 5-hydroxytryptamine turnover in rat brain. Br J Pharmacol (1973) 0.76

Role of the azygos venous system in the investigation of portal hypertension. Gut (1966) 0.75

Clinical and biochemical effects of parachlorophenylalanine in a patient with the carcinoid syndrome. Postgrad Med J (1982) 0.75

Articles by these authors

A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem (1952) 18.27

A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem (1960) 8.08

The physiological disposition and metabolic fate of hydrocortisone in man. J Clin Invest (1955) 6.74

TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. J Biol Chem (1964) 5.40

Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. J Biol Chem (1954) 5.08

A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med (1957) 5.04

The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. J Biol Chem (1955) 4.29

Identification and assay of serotonin in brain. J Pharmacol Exp Ther (1956) 4.17

The chemical estimation of tyrosine and tyramine. J Biol Chem (1952) 4.09

The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther (1957) 3.99

The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 3.60

A chemical method for the determination of free choline in plasma. J Biol Chem (1953) 3.57

ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART. J Pharmacol Exp Ther (1965) 3.45

The estimation of 5-hydroxytryptamine (serotonin) in biological tissues. J Biol Chem (1955) 3.28

Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med (1960) 3.26

On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther (1959) 3.16

Some physico-chemical factors in drug action. J Pharm Pharmacol (1957) 3.13

Enzymatic hydroxylation of aromatic compounds. Arch Biochem Biophys (1956) 3.09

The fate of antipyrine in man. J Pharmacol Exp Ther (1950) 3.05

Serotonin release as a possible mechanism of reserpine action. Science (1955) 3.03

The direct determination of phosphatidyl ethanolamine and phosphatidyl serine in plasma and red blood cells. J Biol Chem (1953) 2.98

Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science (1960) 2.87

A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Am J Med (1956) 2.84

BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther (1965) 2.82

Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem (1954) 2.78

INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS. J Pharmacol Exp Ther (1965) 2.77

A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci (1957) 2.71

Aromatic L-amino acid decarboxylase. J Biol Chem (1962) 2.70

Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther (1958) 2.62

Formation of indole-3-acetic acid and tryptamine in animals: a method for estimation of indole-3-acetic acid in tissues. J Biol Chem (1959) 2.57

The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J Pharmacol Exp Ther (1950) 2.54

The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. J Pharmacol Exp Ther (1957) 2.46

The fate of pentobarbital in man and dog and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 2.38

Enzymatic metabolism of drugs and other foreign compounds. Annu Rev Biochem (1958) 2.36

Incorporation of C14-labeled amino acids into actinomycin and protein by Streptomyces antibioticus. J Biol Chem (1963) 2.29

Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther (1956) 2.26

A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther (1957) 2.20

Detoxication of drugs and other foreign compounds by liver microsomes. Science (1955) 2.20

Effect of iproniazid on serotonin metabolism in vivo. J Pharmacol Exp Ther (1957) 2.16

Estimation of intracellular water in man. Am J Physiol (1950) 2.14

The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain. J Neurochem (1957) 2.13

Evidence that serotonin has a role in brain function. Science (1955) 2.13

Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J Pharmacol Exp Ther (1960) 2.10

The fate of thiopental in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1950) 2.10

A RAPID AND SIMPLE RADIOASSAY FOR TYROSINE HYDROXYLASE ACTIVITY. Anal Biochem (1964) 2.09

The enzymatic conversion of phenylalanine to tyrosine. J Biol Chem (1952) 2.09

A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine. J Biol Chem (1960) 2.08

Isolation and properties of crystalline cobamide coenzymes containing benzimidazole or 5, 6-dimethylbenzimidazole. J Biol Chem (1960) 2.07

Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science (1955) 1.99

Assay, purification, and properties of the adenylocobamide coenzyme. J Biol Chem (1960) 1.94

CONVERSION OF PROLINE TO COLLAGEN HYDROXYPROLINE IN A CELL-FREE SYSTEM FROM CHICK EMBRYO. J Biol Chem (1963) 1.89

Absorption of drugs from the stomach. I. The rat. J Pharmacol Exp Ther (1957) 1.86

Absorption of drugs from the stomach. II. The human. J Pharmacol Exp Ther (1957) 1.85

Fluorescence characteristics of 5-hydroxytryptamine (serotonin). Science (1955) 1.84

Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate. J Pharmacol Exp Ther (1954) 1.78

Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines. J Biol Chem (1955) 1.77

The metabolic fate of phenylbutazone (butazolidin) in man. J Pharmacol Exp Ther (1955) 1.76

Isolation of gamma-aminobutyrylhistidine (homocarnosine) from brain. J Biol Chem (1961) 1.76

Increase in tissue serotonin following administration of its precursor 5-hydroxytryptophan. J Biol Chem (1957) 1.74

Preparation of C14 uniformly labeled fructose by means of photosynthesis and paper chromatography. Science (1949) 1.74

ENZYMATIC HYDROXYLATION OF PROLINE IN MICROSOMAL POLYPEPTIDE LEADING TO FORMATION OF COLLAGEN. Proc Natl Acad Sci U S A (1965) 1.70

The purification and properties of beta-methylaspartase. J Biol Chem (1959) 1.70

Release of inorganic tripolyphosphate from adenosine triphosphate during vitamin B-12 coenzyme biosynthesis. J Biol Chem (1963) 1.69

Further observations on patients with malignant carcinoid. Am J Med (1957) 1.69

5-Hydroxytryptophan decarboxylase: preparation and properties. J Biol Chem (1954) 1.66

Assay of L-phenylalanine as phenylethylamine after enzymatic decarboxylation; application to isotopic studies. J Biol Chem (1953) 1.65

The hydroxylation of phenylalanine and antipyrine in phenylpyruvic oligophrenia. J Biol Chem (1953) 1.64

Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther (1959) 1.63

The physiological disposition and metabolic fate of cortisone in man. J Clin Invest (1957) 1.62

On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine). J Pharmacol Exp Ther (1956) 1.61

Biochemical findings relating to the action of serotonin. Ann N Y Acad Sci (1957) 1.61

STUDIES ON THE TERMINAL REACTION IN THE BIOSYNTHESIS OF METHIONINE. J Biol Chem (1963) 1.60

Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. J Pharmacol Exp Ther (1956) 1.59

Biogenesis and metabolism of 5-hydroxyindole compounds. J Biol Chem (1956) 1.58

A fluorometric procedure for the measurement of tryptamine in tissues. J Pharmacol Exp Ther (1959) 1.56

The enzymatic metabolism of hexobarbital (evipal). J Pharmacol Exp Ther (1955) 1.56

Precursors of adrenal epinephrine and norepinephrine in vivo. Biochim Biophys Acta (1956) 1.56

Possible interrelationship between release of brain norepinephrine and serotonin by reserpine. Science (1957) 1.54

Purification and properties of hydroxyindole-O-methyl transferase. J Biol Chem (1961) 1.54

Identification of gamma-aminobutyric acid in brain by the isotope derivative method. J Biol Chem (1950) 1.52

Serotonin and histamine in mast cells. Science (1957) 1.52

On the nature of enzymatic defect in phenylpyruvic oligophrenia. Proc Soc Exp Biol Med (1957) 1.52

A HYDROXYPROLINE-CONTAINING, COLLAGEN-LIKE PROTEIN IN PLASMA AND A PROCEDURE FOR ITS ASSAY. J Biol Chem (1964) 1.52